Ponezumab (PF-04360365) is a humanised anti-amyloid IgG2 monoclonal antibody. Ponezumab reduces Abeta levels in the central nervous system and improves performance in mice in various models of learning and memory. Ponezumab can be used in study of Alzheimers disease.
Reinheit:
>99.0%
CAS Nummer:
[1178862-65-1]
Target-Kategorie:
EGFR/HER2
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten